Siloam International Hospitals Tbk PT Financials

Market Capitalization €1.48 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	13.10
Forward PE
Price to Sales TTM	€0.00
Price to Book MRQ	€0.00
Enterprise to Revenue	0.10
Enterprise to EBITDA	0.58

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	9.29%
Operating Margin	12.53%
Return on Assets TTM	8.47%
Return on Equity TTM	13.83%

Income Statement

Revenue TTM	€639,586,816
Revenue per Share TTM	€940.92
Quarterly Revenue Growth	0.30%
Gross Profit TTM	€240,921,019
EBITDA	€2,546,739,000,000
Net Income to Common TTM	€59,388,876
Diluted EPS TTM	€69.19
Quarterly Earnings Growth YoY	1698.60%

Balance Sheet

Total Cash MRQ	€47,348,951
Total Cash per Share MRQ	€69.64
Total Debt MRQ	€
Total Debt to Equity MRQ	21.72
Current Ratio MRQ	0.72
Book Value per Share MRQ	€679.50

Cash Flow

Operating Cash Flow TTM	€122,438,371
Levered Free Cash Flow TTM	€37,263,390

2LS Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	12,988,513,353
Float Shares	1,337,037,565
Avg 10 Volume	534
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	92.75%
% Held by Institutions	1.48%

Stock Price Summary

Beta	0.20
Fifty Two Week Low	€0.10
Fifty Two Week High	€0.19
Fifty Two Week Change	-38.32%
Day 50 MA	€0.11
Day 200 MA	€0.15

Dividends and Splits

Forward Annual Dividend Rate	€0.00
Forward Annual Dividend Yield	3.90%
Trailing Annual Dividend Rate	€0.00
Trailing Annual Dividend Yield	0.98%
Payout Ratio	22.97%
Dividend Date
Ex Dividend Date	2024-06-10
Last Split Factor
Last Split Date	2022-04-08